Dexcom (NSDQ:DXCM) announced today that it launched the new Dexcom One continuous glucose monitoring (CGM) system in the United Kingdom. San Diego-based Dexcom designed the Dexcom One system as an easy-to-use, real-time CGM (rt-CGM) that it aims to make more affordable and accessible for people with diabetes in the UK. According to a news release, […]
Big Data
Pear Therapeutics joins Epic App Orchard to enable monitoring of its digital therapeutics
Pear Therapeutics (Nasdaq:PEAR) announced today that its PearConnect platform is now available in the Epic App Orchard Gallery. By making PearConnect available to healthcare providers through the Epic App Orchard Gallery, the providers who implement the application will be able to access PearConnect within Epic’s electronic health record (EHR) platform, allowing them to monitor patients […]
9am.health partners with Ascensia to add blood glucose meter to diabetes toolkit
9am.health announced today that it now offers the Ascensia Diabetes Care Contour Next One and Contour Next products in its diabetes kit. Patients with type 2 diabetes and prediabetes can now add Ascensia’s Contour Next One blood glucose meter and Contour Next glucose test strips to a personalized treatment plan as part of the all-in-one […]
Diabetes tech is off to a hot start in 2022
Diabetes tech developers have high hopes for the year ahead, some of which have already come to fruition. Change is continuous in continuous glucose monitoring (GCM), with expanded wear-times, improved accuracy and more. Meanwhile, never-ending innovation in insulin delivery is delivering wearable patches and closedloop delivery systems, making insulin management easier for people with diabetes. […]
Dexcom says data shows next-gen G7 CGM provides accurate glucose readings
Dexcom (NSDQ:DXCM) published study results that demonstrate the accuracy offered by its next-generation G7 continuous glucose meter. San Diego-based Dexcom — which expects to launch the G7 soon ahead of what President and CEO Kevin Sayer said will be a year full of activity — conducted the study in adults with either type 1 or type […]
With FDA clearance ‘imminent’ for Senseonics 180-day CGM, what’s next?
When Dr. Fran Kaufman began her career in the late 1970s, diabetes management consisted of urine testing and animal insulin. At that point, it had not been proven that managing glucose actually mattered, according to Kaufman, and proof didn’t come until 1992 with the conclusion of the DCCT study. “I’ve seen a lot of innovation,” […]
How Bigfoot Biomedical plans to take diabetes management forward
For close to 20 years, Jeffrey Brewer has focused on finding ways to support insulin delivery and manage diabetes. Initially an entrepreneur, Brewer got involved with the Juvenile Diabetes Research Foundation (JDRF) and the Artificial Pancreas Project for developing a closed-loop insulin delivery system after his son was diagnosed with type 1 diabetes. After spending […]
Glytec enters insulin management partnership with Nebraska Medicine
Glytec announced today that it entered into a strategic partnership with Nebraska Medicine to advance patient safety and innovation in insulin management. Under the agreement, Nebraska Medicine will implement Glytec’s eGlycemic Management System (eGMS) across all 800 beds at its two hospitals: the Nebraska Medical Center and Bellevue Medical Center. The agreement also includes collaboration […]
Ahead of G7 launch, Dexcom CEO plans for ‘more activity than we’ve ever seen’ in 2022
With a major product approval and launch in its sights, Dexcom prepares for a big year in 2022. Across 2021, Dexcom (NSDQ:DXCM) took several steps forward. The company touted its next-generation G7 continuous glucose monitor (CGM) and announced a significant regulatory nod and partnership for real-time application programming interfaces (APIs), to list a couple. As […]
Glytec partners with Roche to enhance insulin dosing decision support software
Glytec announced today that it entered into a strategic partnership with Roche Diagnostics USA for a digital health collaboration. Waltham, Massachusetts-based Glytec’s partnership combines its FDA-cleared Glucommander insulin dosing decision support software with Roche’s expertise in medical devices and IT solutions in an effort to address the challenges associated with inpatient blood sugar management at […]